However, the correlations of MITF expression with immune responses in patients with immunological diseases or cancers, including melanoma, and with the response to immune checkpoint inhibitors (ICIs) used to treat various tumor types have recently been investigated (Fig. 1). Here, MITF is linked to cancer.